Google
BHC — BAUSCH HEALTH COMPANIES INC (Healthcare >> Drug Manufacturers - Specialty & Generic)
BHC FAQ
What is BHC's P/E ratio?
BAUSCH HEALTH COMPANIES INC (BHC) currently trades at a P/E ratio of 8.66.
What is BHC's ROE?
BAUSCH HEALTH COMPANIES INC reports a Return on Equity (ROE) of 57.77%.
What is BHC's dividend yield?
BAUSCH HEALTH COMPANIES INC offers a dividend yield of 0.00%.
What is BHC's Deepscope Quality Score?
Deepscope rates BHC's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BHC?
Deepscope's AI Timing Score for BHC is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BHC belong to?
BAUSCH HEALTH COMPANIES INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange.
|
USD 5.15
Price
-0.02
(-0.39%)
Day Change
|
|
|---|
BHC, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 94 |
| Magic Formula Rank by ROA |
1955
|
| Magic Formula Rank by ROE |
1955
|
| Magic Formula Rank by ROIC |
698
|
| Price | 5.15 |
| PBV / Sector |
-1.78 / 2.63
|
| Earning Per Share | -3.17 |
| PE / Sector |
8.66 / 24.12
GREAT
|
| PEG or PE/Growth / Sector |
-0.07 / 0.13
|
| Average 1M Daily Value |
9.40 M
|
| Average 1W Daily Value |
10.85 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-11 09:54:53 |
| Symbol | BHC |
| Name | BAUSCH HEALTH COMPANIES INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 373.48 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,930.87 / 9,930.86 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2150 St. Elzéar Blvd. West, Laval, QC, Canada, H7L 4A8
Phone: 514 744 6792
Website: https://www.bauschhealth.com
Employees: 20,300
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
